LHCIX vs. FPHAX

Last updated Jun 6, 2026

LHCIX (Lord Abbett Health Care Fund) and FPHAX (Fidelity Select Pharmaceuticals Portfolio) are both Health & Biotech Equities funds. Over the past 5 years, LHCIX returned 3.79%/yr vs 13.65%/yr for FPHAX. Their correlation of 0.81 suggests significant overlap in exposure. LHCIX charges 0.78%/yr vs 0.75%/yr for FPHAX.

Performance

LHCIX vs. FPHAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lord Abbett Health Care Fund (LHCIX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LHCIX achieves a -4.44% return, which is significantly lower than FPHAX's 11.03% return.

LHCIX

• 1D: 2.60%
• 1M: -1.50%
• YTD: -4.44%
• 6M: -5.27%
• 1Y: 18.45%
• 3Y*: 5.92%
• 5Y*: 3.79%
• 10Y*: —

FPHAX

• 1D: 2.73%
• 1M: 5.22%
• YTD: 11.03%
• 6M: 12.78%
• 1Y: 43.20%
• 3Y*: 18.54%
• 5Y*: 13.65%
• 10Y*: 11.74%

*Multi-year figures are annualized to reflect compound growth (CAGR)

LHCIX vs. FPHAX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
LHCIX Lord Abbett Health Care Fund	-4.44%	17.94%	7.60%	3.20%	-11.79%	8.39%	37.19%	8.05%
FPHAX Fidelity Select Pharmaceuticals Portfolio	11.03%	30.41%	9.39%	12.54%	0.94%	11.79%	11.16%	18.70%

Correlation

The correlation between LHCIX and FPHAX is 0.79, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.79
Correlation (3Y) Calculated over the trailing 3-year period	0.79
Correlation (5Y) Calculated over the trailing 5-year period	0.81
Correlation (All Time) Calculated using the full available price history since Aug 1, 2019	0.81

The correlation between LHCIX and FPHAX has been stable across timeframes, ranging from 0.79 to 0.81 - a consistent structural relationship.

Return for Risk

LHCIX vs. FPHAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LHCIX

LHCIX Risk / Return Rank: 17
LHCIX Sharpe Ratio Rank: 18
LHCIX Sortino Ratio Rank: 18
LHCIX Omega Ratio Rank: 17
LHCIX Calmar Ratio Rank: 19
LHCIX Martin Ratio Rank: 14

FPHAX

FPHAX Risk / Return Rank: 62
FPHAX Sharpe Ratio Rank: 58
FPHAX Sortino Ratio Rank: 56
FPHAX Omega Ratio Rank: 49
FPHAX Calmar Ratio Rank: 88
FPHAX Martin Ratio Rank: 58

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LHCIX vs. FPHAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lord Abbett Health Care Fund (LHCIX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LHCIX	FPHAX	Difference
Sharpe ratio: Return per unit of total volatility	1.14	2.18	-1.04
Sortino ratio: Return per unit of downside risk	1.71	3.03	-1.32
Omega ratio: Gain probability vs. loss probability	1.20	1.37	-0.16
Calmar ratio: Return relative to maximum drawdown	1.46	4.27	-2.81
Martin ratio: Return relative to average drawdown	3.65	11.12	-7.47
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LHCIX vs. FPHAX - Sharpe Ratio Comparison

The current LHCIX Sharpe Ratio is 1.14, which is lower than the FPHAX Sharpe Ratio of 2.18. The chart below compares the historical Sharpe Ratios of LHCIX and FPHAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	LHCIX	FPHAX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.14	2.18	-1.04
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.21	0.76	-0.55
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.66	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.42	0.55	-0.13

Drawdowns

LHCIX vs. FPHAX - Drawdown Comparison

The maximum LHCIX drawdown since its inception was -27.92%, smaller than the maximum FPHAX drawdown of -38.26%. Use the drawdown chart below to compare losses from any high point for LHCIX and FPHAX.

Drawdown Indicators

	LHCIX	FPHAX	Difference
Max Drawdown Largest peak-to-trough decline	-27.92%	-38.26%	+10.34%
Max Drawdown (1Y) Largest decline over 1 year	-13.03%	-10.33%	-2.70%
Max Drawdown (3Y) Largest decline over 3 years	-20.27%	-28.82%	+8.55%
Max Drawdown (5Y) Largest decline over 5 years	-27.19%	-28.82%	+1.63%
Max Drawdown (10Y) Largest decline over 10 years	—	-28.82%	—
Current Drawdown Current decline from peak	-8.57%	0.00%	-8.57%
Average Drawdown Average peak-to-trough decline	-9.05%	-9.17%	+0.12%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.21%	3.96%	+1.25%

Volatility

LHCIX vs. FPHAX - Volatility Comparison

Lord Abbett Health Care Fund (LHCIX) has a higher volatility of 6.64% compared to Fidelity Select Pharmaceuticals Portfolio (FPHAX) at 5.82%. This indicates that LHCIX's price experiences larger fluctuations and is considered to be riskier than FPHAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LHCIX	FPHAX	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.64%	5.82%	+0.82%
Volatility (6M) Calculated over the trailing 6-month period	13.38%	14.23%	-0.85%
Volatility (1Y) Calculated over the trailing 1-year period	16.75%	20.29%	-3.54%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.36%	18.08%	+0.28%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	20.76%	17.88%	+2.88%

LHCIX vs. FPHAX - Expense Ratio Comparison

LHCIX has a 0.78% expense ratio, which is higher than FPHAX's 0.75% expense ratio.

Dividends

LHCIX vs. FPHAX - Dividend Comparison

LHCIX's dividend yield for the trailing twelve months is around 0.38%, less than FPHAX's 5.01% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FPHAX Fidelity Select Pharmaceuticals Portfolio	5.01%	5.68%	1.90%	8.08%	5.18%	11.09%	8.85%	8.33%	1.65%	1.62%	1.07%	12.63%
LHCIX Lord Abbett Health Care Fund	0.38%	0.36%	0.57%	0.00%	0.14%	7.40%	11.70%	0.05%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both LHCIX and FPHAX in my portfolio?

LHCIX and FPHAX have a correlation of 0.79, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LHCIX or FPHAX?

LHCIX has higher volatility (6.64%) compared to FPHAX (5.82%). In terms of maximum drawdown, LHCIX dropped -27.92% vs FPHAX's -38.26%.

Which has better risk-adjusted returns?

FPHAX currently has the higher Sharpe Ratio (2.18 vs 1.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.